Venetoclax Tablets 100 mg

  • Venetoclax Tablets 100 mg 1
  • Venetoclax Tablets 100 mg 2
Product Description

Description: Oral targeted anticancer medication containing venetoclax, primarily used in the treatment of certain hematological malignancies such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).

Therapeutic Category: Antineoplastic / Targeted Therapy

Mechanism of Action (MOA): Venetoclax selectively inhibits the BCL-2 protein, which helps cancer cells survive. Blocking BCL-2 triggers programmed cell death (apoptosis) in malignant cells.

This helps:
• Promote death of cancer cells
• Reduce tumor burden
• Improve response in blood cancers
• Enhance overall treatment outcomes 

Read more Show less

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Swasthya Healthcare Private Limited (31)

  • Ibrutinib Capsules 140 mg

    Product Ibrutinib Capsules 140 mg

    Description: Oral targeted anticancer medication containing ibrutinib, used in the treatment of various B-cell malignancies such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma.

    Therapeutic Category: Antineoplastic / Targeted Therapy

    ...
  • Bortezomib Injection 3.5 mg

    Product Bortezomib Injection 3.5 mg

    Description: Sterile injectable formulation containing bortezomib, a proteasome inhibitor used in the treatment of certain hematological cancers. Administered intravenously or subcutaneously under medical supervision.

    Therapeutic Category: Antineoplastic / Targeted Therapy ...
  • Deferasirox 250mg

    Product Deferasirox 250mg

    Description: Oral iron chelating agent used for the treatment of chronic iron overload caused by repeated blood transfusions. Available as film-coated or dispersible tablets.

    Therapeutic Category: Iron Chelator / Hematology

    Mechanism of Action (MOA): Deferasirox b...
  • Fingolimod 0.50mg Capsule

    Product Fingolimod 0.50mg Capsule

    Description: Oral immunomodulatory medication used primarily in the treatment of relapsing forms of multiple sclerosis. It helps reduce disease activity and progression.

    Therapeutic Category: Immunomodulator / Neurology

    Mechanism of Action (MOA): ...
  • Enoxaparin Sodium Injection USP 40 mg/0.4 ml

    Product Enoxaparin Sodium Injection USP 40 mg/0.4 ml

    Description: Sterile injectable solution containing enoxaparin sodium, a low molecular weight heparin (LMWH) used for prevention and treatment of blood clots. Administered subcutaneously or intravenously under medical supervision.

    Therapeutic Category: Antic...
  • Pembrolizumab 100 mg/4 ml

    Product Pembrolizumab 100 mg/4 ml

    Description: Sterile injectable formulation of pembrolizumab, a monoclonal antibody used in immunotherapy. It enhances the body’s immune response against tumor cells by targeting immune checkpoint pathways. Commonly used in the treatment of various cancers, including melanoma, lung cancer, and other advan...
  • Apalutamide Tablets

    Product Apalutamide Tablets

    Description: Oral anticancer medication containing apalutamide, used in the treatment of prostate cancer. It is designed to inhibit androgen receptor signaling involved in tumor growth.

    Therapeutic Category: Antineoplastic / Hormonal Therapy / Targeted Therapy

    ...
  • Eltrombopag 25mg

    Product Eltrombopag 25mg

    Description: Oral medication containing eltrombopag, a thrombopoietin receptor agonist used to increase platelet production in patients with certain hematological conditions.

    Therapeutic Category: Thrombopoietin Receptor Agonist / Hematologic Agent
    ...
  • Mirogabalin Besylate

    Product Mirogabalin Besylate

    Description: Oral neuropathic pain management therapy containing mirogabalin besylate, developed to provide targeted relief in peripheral neuropathic pain conditions. Designed for effective symptom control with improved patient tolerability.

    Therapeutic Category: Neurology ...
  • Acalabrutinib Capsule 100 mg

    Product Acalabrutinib Capsule 100 mg

    Description: Oral capsule formulation of acalabrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor. It is designed to interfere with B-cell receptor signaling, thereby reducing the growth and survival of malignant B-cells. Commonly used in the treatment of certain hematological malignancies.
    ...
  • Fulvestrant Injectable Solution 250 mg/5 ml

    Product Fulvestrant Injectable Solution 250 mg/5 ml

    Description: Sterile oily injectable solution containing fulvestrant, an estrogen receptor antagonist used in the treatment of hormone receptor-positive breast cancer. Administered via intramuscular injection.

    Therapeutic Category: Antineoplastic / Hormonal Therapy
    ...
  • Conjugated Estrogen Vaginal Cream

    Product Conjugated Estrogen Vaginal Cream

    Description:
    Topical hormonal formulation containing conjugated estrogens, specially designed to relieve symptoms associated with vaginal atrophy and estrogen deficiency during menopause. Provides localized estrogen therapy with targeted comfort and restoration.

    Therapeutic Category: Hormonal T...
show all 31 other products

Swasthya Healthcare Private Limited resources (3)